Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ACE1831
i
Other names:
ACE1831, ACE-NgdT-CD20, CD20 targeting ACC-gamma delta T cell therapy, CD20 targeting ACC-γδ T cell therapy, anti-CD20 conjugated NgdT cells, ACE-1831, ACE 1831
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Acepodia
Drug class:
CD20 inhibitor, γδ TCR modulator
Related drugs:
‹
rituximab (174)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
mosunetuzumab-axgb (2)
rituximab-arrx (2)
IMM0306 (2)
IGM-2323 (2)
AR160 (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACTR087 (0)
ALETA-001 (0)
AcellBia (rituximab biosimilar) (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CM355 (0)
CMG1A46 (0)
DI Leu16 IL-2 (0)
(0)
GB241 (rituximab biosimilar) (0)
GB261 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MIL62 (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
ocrelizumab (0)
PRO131921 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
IGN002 (0)
AME-133v (0)
XmAb13676 (0)
TG20 (rituximab biosimilar) (0)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ADI-001 (1)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
QH104 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
rituximab (174)
obinutuzumab (68)
epcoritamab-bysp (11)
ofatumumab (8)
ublituximab-xiiy (7)
rituximab-pvvr (6)
rituximab-abbs (6)
rituximab/hyaluronidase (5)
Rixathon (rituximab biosimilar) (4)
EX103 (3)
ibritumomab tiuxetan (3)
mosunetuzumab-axgb (2)
rituximab-arrx (2)
IMM0306 (2)
IGM-2323 (2)
AR160 (2)
glofitamab-gxbm (1)
TQB2303 (rituximab biosimilar) (1)
IPH6501 (1)
odronextamab (1)
Ritucad (rituximab biosimilar) (1)
ACTR087 (0)
ALETA-001 (0)
AcellBia (rituximab biosimilar) (0)
ripertamab (0)
zuberitamab (0)
Avetux (rituximab biosimilar) (0)
B001 (0)
BAT4306F (0)
BI 695500 (rituximab biosimilar) (0)
BM-ca (0)
CHO-H01 (0)
CIMAbior (rituximab biosimilar) (0)
CM355 (0)
CMG1A46 (0)
DI Leu16 IL-2 (0)
(0)
GB241 (rituximab biosimilar) (0)
GB261 (0)
Halpryza (rituximab biosimilar) (0)
Hanlikon (rituximab biosimilar) (0)
Reditux (rituximab biosimilar) (0)
JHL1101 (rituximab biosimilar) (0)
JMT601 (0)
JNJ-8543 (0)
JS203 (0)
Kikuzubam (rituximab biosimilar) (0)
FBTA05 (0)
MIL62 (0)
MK-8808 (rituximab biosimilar) (0)
MT-3724 (0)
MabionCD20 (rituximab biosimilar) (0)
Mabtas (rituximab biosimilar) (0)
NAV-006 (0)
Novex (rituximab biosimilar) (0)
ocrelizumab (0)
PRO131921 (0)
PSB202 (0)
Retuxira (rituximab biosimilar) (0)
SAIT101 (rituximab biosimilar) (0)
SIBP-02 (rituximab biosimilar) (0)
TQB2825 (0)
TRU-015 (0)
veltuzumab (0)
IGN002 (0)
AME-133v (0)
XmAb13676 (0)
TG20 (rituximab biosimilar) (0)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ADI-001 (1)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
QH104 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login